1. Home
  2. LBPH vs VITL Comparison

LBPH vs VITL Comparison

Compare LBPH & VITL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LBPH
  • VITL
  • Stock Information
  • Founded
  • LBPH 2020
  • VITL 2007
  • Country
  • LBPH United States
  • VITL United States
  • Employees
  • LBPH N/A
  • VITL N/A
  • Industry
  • LBPH Biotechnology: Pharmaceutical Preparations
  • VITL Packaged Foods
  • Sector
  • LBPH Health Care
  • VITL Consumer Staples
  • Exchange
  • LBPH Nasdaq
  • VITL Nasdaq
  • Market Cap
  • LBPH 1.4B
  • VITL 1.5B
  • IPO Year
  • LBPH 2021
  • VITL 2020
  • Fundamental
  • Price
  • LBPH $59.81
  • VITL $31.03
  • Analyst Decision
  • LBPH Buy
  • VITL Strong Buy
  • Analyst Count
  • LBPH 8
  • VITL 7
  • Target Price
  • LBPH $52.29
  • VITL $35.67
  • AVG Volume (30 Days)
  • LBPH 834.8K
  • VITL 1.2M
  • Earning Date
  • LBPH 11-07-2024
  • VITL 11-07-2024
  • Dividend Yield
  • LBPH N/A
  • VITL N/A
  • EPS Growth
  • LBPH N/A
  • VITL 151.76
  • EPS
  • LBPH N/A
  • VITL 1.12
  • Revenue
  • LBPH N/A
  • VITL $576,129,000.00
  • Revenue This Year
  • LBPH N/A
  • VITL $29.66
  • Revenue Next Year
  • LBPH N/A
  • VITL $18.56
  • P/E Ratio
  • LBPH N/A
  • VITL $27.61
  • Revenue Growth
  • LBPH N/A
  • VITL 29.14
  • 52 Week Low
  • LBPH $3.60
  • VITL $12.44
  • 52 Week High
  • LBPH $59.95
  • VITL $48.41
  • Technical
  • Relative Strength Index (RSI)
  • LBPH 78.81
  • VITL 43.00
  • Support Level
  • LBPH $59.47
  • VITL $28.00
  • Resistance Level
  • LBPH $59.85
  • VITL $37.29
  • Average True Range (ATR)
  • LBPH 0.20
  • VITL 1.84
  • MACD
  • LBPH -0.84
  • VITL -0.09
  • Stochastic Oscillator
  • LBPH 86.36
  • VITL 33.26

About LBPH Longboard Pharmaceuticals Inc.

Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. The company is working to improve a portfolio of centrally acting product candidates designed to be selective for specific G protein-coupled receptors (GPCRs). The company is evaluating LP352, an oral, centrally acting 5-hydroxytryptamine 2C (5-HT2C) receptor superagonist, with negligible observed impact on 5-HT2B and 5-HT2A receptor subtypes, in development for the potential treatment of seizures associated with a broad range of developmental and epileptic encephalopathies.

About VITL Vital Farms Inc.

Vital Farms Inc is an ethical food company. The company retails pasture-raised eggs and butter. Its products include Pasture-Raised Eggs and Pasture-Raised Butter & Ghee. The company's purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of its stakeholders (farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders).

Share on Social Networks: